Trends in Antibacterial Use in Hospitalized Pediatric Patients in United States Academic Health Centers

• Published in: Infection control and hospital epidemiology Vol. 30; no. 6; pp. 600 - 603
• Main Authors: Pakyz, Amy L., Gurgle, Holly E., Ibrahim, Omar M., Oinonen, Michael J., Polk, Ronald E.
• Format: Journal Article
• Language: English
• Published: Chicago, IL The University of Chicago Press 01-06-2009; University of Chicago Press
• Subjects: Academic Medical Centers - statistics & numerical data; Acetamides - therapeutic use; Adolescent; Aminoglycosides; Aminoglycosides - therapeutic use; Anti-Bacterial Agents - therapeutic use; Antibacterial agents; Antibacterials; Antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Biological and medical sciences; Cephalosporins; Child; Child, Preschool; Concise Communication; Dosage; Drug Utilization - trends; Health care industry; Hospitalization - statistics & numerical data; Humans; Infant; Infant, Newborn; Linezolid; Macrolides; Macrolides - therapeutic use; Medical sciences; Miscellaneous; Nursing; Oxazolidinones - therapeutic use; Pediatrics; Penicillin; Pharmacology. Drug treatments; Public health. Hygiene; Public health. Hygiene-occupational medicine; Statistical significance; United States; United States; North America; America; Human; Infection; Health center; Hospitalization; Antibacterial agent; Child; Public health
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1086/597545

Trends in pediatric antibacterial use were examined in 20 academic health centers during the period 2002–2007. There was a significant increase in the use of linezolid (
\documentclass{aastex}
\usepackage{amsbsy}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{bm}
\usepackage{mathrsfs}
\usepackage{pifont}
\usepackage{stmaryrd}
\usepackage{textcomp}
\usepackage{portland,xspace}
\usepackage{amsmath,amsxtra}
\usepackage[OT2,OT1]{fontenc}
\newcommand\cyr{
\renewcommand\rmdefault{wncyr}
\renewcommand\sfdefault{wncyss}
\renewcommand\encodingdefault{OT2}
\normalfont
\selectfont}
\DeclareTextFontCommand{\textcyr}{\cyr}
\pagestyle{empty}
\DeclareMathSizes{10}{9}{7}{6}
\begin{document}
\landscape
$P< .001$
\end{document}
) and of macrolides (
\documentclass{aastex}
\usepackage{amsbsy}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{bm}
\usepackage{mathrsfs}
\usepackage{pifont}
\usepackage{stmaryrd}
\usepackage{textcomp}
\usepackage{portland,xspace}
\usepackage{amsmath,amsxtra}
\usepackage[OT2,OT1]{fontenc}
\newcommand\cyr{
\renewcommand\rmdefault{wncyr}
\renewcommand\sfdefault{wncyss}
\renewcommand\encodingdefault{OT2}
\normalfont
\selectfont}
\DeclareTextFontCommand{\textcyr}{\cyr}
\pagestyle{empty}
\DeclareMathSizes{10}{9}{7}{6}
\begin{document}
\landscape
$P=.001$
\end{document}
) and a significant decrease in the use of aminoglycosides (
\documentclass{aastex}
\usepackage{amsbsy}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{bm}
\usepackage{mathrsfs}
\usepackage{pifont}
\usepackage{stmaryrd}
\usepackage{textcomp}
\usepackage{portland,xspace}
\usepackage{amsmath,amsxtra}
\usepackage[OT2,OT1]{fontenc}
\newcommand\cyr{
\renewcommand\rmdefault{wncyr}
\renewcommand\sfdefault{wncyss}
\renewcommand\encodingdefault{OT2}
\normalfont
\selectfont}
\DeclareTextFontCommand{\textcyr}{\cyr}
\pagestyle{empty}
\DeclareMathSizes{10}{9}{7}{6}
\begin{document}
\landscape
$P< .001$
\end{document}
) and of first‐generation cephalosporins (
\documentclass{aastex}
\usepackage{amsbsy}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{bm}
\usepackage{mathrsfs}
\usepackage{pifont}
\usepackage{stmaryrd}
\usepackage{textcomp}
\usepackage{portland,xspace}
\usepackage{amsmath,amsxtra}
\usepackage[OT2,OT1]{fontenc}
\newcommand\cyr{
\renewcommand\rmdefault{wncyr}
\renewcommand\sfdefault{wncyss}
\renewcommand\encodingdefault{OT2}
\normalfont
\selectfont}
\DeclareTextFontCommand{\textcyr}{\cyr}
\pagestyle{empty}
\DeclareMathSizes{10}{9}{7}{6}
\begin{document}
\landscape
$P< .001$
\end{document}
).